HLS Therapeutics Inc.
Sector
Industries
Location
Market Cap
USD 116.43 M
Share Price
USD 3.68
Avg Daily Volume
10,879
Change (1 day)
Change (1 year)
Change (YTD)
Eli Lilly and Company
USD 639.43
LLY
Neurocrine Biosciences, Inc.
USD 128.89
NBIX
Corcept Therapeutics Incorporated
USD 73.59
CORT
Jazz Pharmaceuticals plc
USD 113.33
JAZZ
SK Biopharmaceuticals Co., Ltd.
USD 71.98
326030.KS
H. Lundbeck A/S
USD 5.50
HLUN-B.CO
Axsome Therapeutics, Inc.
USD 105.23
AXSM
Alkermes plc
USD 27.43
ALKS
ACADIA Pharmaceuticals Inc.
USD 25.45
ACAD
Sumitomo Pharma Co., Ltd.
USD 9.39
4506.T
Indivior PLC
USD 22.84
INDV
Supernus Pharmaceuticals, Inc.
USD 41.24
SUPN
AbbVie Inc.
USD 198.64
ABBV
Roche Holding AG
USD 320.12
RO.SW
AstraZeneca PLC
USD 150.15
AZN.L
Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
---|
Eli Lilly and Company
USD 639.43
LLY
Neurocrine Biosciences, Inc.
USD 128.89
NBIX
Corcept Therapeutics Incorporated
USD 73.59
CORT
Jazz Pharmaceuticals plc
USD 113.33
JAZZ
SK Biopharmaceuticals Co., Ltd.
USD 71.98
326030.KS
H. Lundbeck A/S
USD 5.50
HLUN-B.CO
Axsome Therapeutics, Inc.
USD 105.23
AXSM
Alkermes plc
USD 27.43
ALKS
ACADIA Pharmaceuticals Inc.
USD 25.45
ACAD
Sumitomo Pharma Co., Ltd.
USD 9.39
4506.T
Indivior PLC
USD 22.84
INDV
Supernus Pharmaceuticals, Inc.
USD 41.24
SUPN
AbbVie Inc.
USD 198.64
ABBV
Roche Holding AG
USD 320.12
RO.SW
AstraZeneca PLC
USD 150.15
AZN.L